Histone modification mapping in human brain reveals aberrant expression of histone H3 lysine 79 dimethylation in neural tube defects

Neurobiology of Disease

Volumn 54, Issue , 2013, Pages 404-413

  Zhang, Qin ^a   Xue, Peng ^b   Li, Huili ^a   Bao, Yihua ^a   Wu, Lihua ^a   Chang, Shaoyan ^a   Niu, Bo ^a   Yang, Fuquan ^b   Zhang, Ting ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

^b INSTITUTE OF BIOPHYSICS   (China)

Author keywords

H3K79me2; Histone modifications; Human brain; Neural tube defects; Proteomics

Indexed keywords

HISTONE H1; HISTONE H2A; HISTONE H2B; HISTONE H3; HISTONE H3 LYSINE 79; HISTONE H4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EMBRYONIC STEM CELL; FEMALE; FETUS; FOLLOW UP; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; ITGA3 GENE; MALE; MASS SPECTROMETRY; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEOMICS; RARA GENE; SPINAL DYSRAPHISM; SUFU GENE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHROMATIN IMMUNOPRECIPITATION; FEMALE; FETUS; HISTONES; HUMANS; LYSINE; MALE; METHYLATION; MICE; NEURAL TUBE DEFECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TANDEM MASS SPECTROMETRY;

EID: 84876323943     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.01.014     Document Type: Article

References (50)

1. Akbarian S., Huang H.S. Epigenetic regulation in human brain-focus on histone lysine methylation. Biol. Psychiatry 2009, 65:198-203.
2. Bonaldi T., et al. A combination of different mass spectroscopic techniques for the analysis of dynamic changes of histone modifications. Proteomics 2004, 4:1382-1396.
3. Bower C., et al. Neural tube defects in Australia: trends in encephaloceles and other neural tube defects before and after promotion of folic acid supplementation and voluntary food fortification. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85:269-273.
4. Chan A.C., et al. Folate awareness and the prevalence of neural tube defects in South Australia, 1966-2007. Med. J. Aust. 2008, 189:566-569.
5. Czeizel A.E., et al. Prevention of neural-tube defects with periconceptional folic acid, methylfolate, or multivitamins. Ann. Nutr. Metab. 2011, 58:263-271.
6. Garcia B.A., et al. Organismal differences in post-translational modifications in histones H3 and H4. J. Biol. Chem. 2007, 282:7641-7655.
7. Garcia B.A., et al. Tissue-specific expression and post-translational modification of histone H3 variants. J. Proteome Res. 2008, 7:4225-4236.
8. Gu X., et al. High prevalence of NTDs in Shanxi Province: a combined epidemiological approach. Birth Defects Res. A Clin. Mol. Teratol. 2007, 79:702-707.
9. Hake S.B., et al. Extraction, purification and analysis of histones. Nat. Protoc. 2007, 2:1445-1457.
10. Heseker H. Folic acid and other potential measures in the prevention of neural tube defects. Ann. Nutr. Metab. 2011, 59:41-45.
11. Hosako H., et al. Gene and microRNA expression in p53-deficient day 8.5 mouse embryos. Birth Defects Res. A Clin. Mol. Teratol. 2009, 85:546-555.
12. Hou J.J., et al. Phosphoproteome analysis of rat L6 myotubes using reversed-phase C18 prefractionation and titanium dioxide enrichment. J. Proteome Res. 2010, 9:777-788.
13. Im H., et al. Dynamic regulation of histone H3 methylated at lysine 79 within a tissue-specific chromatin domain. J. Biol. Chem. 2003, 278:18346-18352.
14. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
15. Jones B., et al. The histone H3K79 methyltransferase Dot1L is essential for mammalian development and heterochromatin structure. PLoS Genet. 2008, 4:e1000190.
16. Kibar Z., et al. Novel mutations in VANGL1 in neural tube defects. Hum. Mutat. 2009, 30:E706-E715.
17. Kibar Z., et al. Contribution of VANGL2 mutations to isolated neural tube defects. Clin. Genet. 2011, 80:76-82.
18. Li B., et al. The role of chromatin during transcription. Cell 2007, 128:707-719.
19. Lu X., et al. The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure. Nat. Struct. Mol. Biol. 2008, 15:1122-1124.
20. Martin C., Zhang Y. The diverse functions of histone lysine methylation. Nat. Rev. Mol. Cell Biol. 2005, 6:838-849.
21. Miao F., Natarajan R. Mapping global histone methylation patterns in the coding regions of human genes. Mol. Cell. Biol. 2005, 25:4650-4661.
22. Mohan M., et al. Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). Genes Dev. 2010, 24:574-589.
23. Mulinare J., et al. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988, 260:3141-3145.
24. Muller-Taubenberger A., et al. The histone methyltransferase Dot1 is required for DNA damage repair and proper development in Dictyostelium. Biochem. Biophys. Res. Commun. 2011, 404:1016-1022.
25. Muskiet F.A. The importance of (early) folate status to primary and secondary coronary artery disease prevention. Reprod. Toxicol. 2005, 20:403-410.
26. Ng H.H., et al. Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association. Genes Dev. 2002, 16:1518-1527.
27. Ng H.H., et al. Lysine-79 of histone H3 is hypomethylated at silenced loci in yeast and mammalian cells: a potential mechanism for position-effect variegation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:1820-1825.
28. Nguyen A.T., Zhang Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 2011, 25:1345-1358.
29. Onder T.T., et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 2012, 483:598-602.
30. Park L.K., et al. Nutritional influences on epigenetics and age-related disease. Proc. Nutr. Soc. 2012, 71:75-83.
31. Pramparo T., et al. Loss-of-function mutation of the AF9/MLLT3 gene in a girl with neuromotor development delay, cerebellar ataxia, and epilepsy. Hum. Genet. 2005, 118:76-81.
32. Ryu H., et al. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19176-19181.
33. Schubeler D., et al. The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev. 2004, 18:1263-1271.
34. Shi Y. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat. Rev. Genet. 2007, 8:829-833.
35. Sims R.J., et al. Histone lysine methylation: a signature for chromatin function. Trends Genet. 2003, 19:629-639.
36. Smithells R.W., et al. Vitamin dificiencies and neural tube defects. Arch. Dis. Child. 1976, 51:944-950.
37. Smithells R.W., et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch. Dis. Child. 1981, 56:911-918.
38. Svard J., et al. Genetic elimination of suppressor of fused reveals an essential repressor function in the mammalian Hedgehog signaling pathway. Dev. Cell 2006, 10:187-197.
39. Tan M., et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 2011, 146:1016-1028.
40. Tibbetts A.S., Appling D.R. Compartmentalization of mammalian folate-mediated one-carbon metabolism. Annu. Rev. Nutr. 2010, 30:57-81.
41. Tran P.X., et al. Association of retinoic acid receptor genes with meningomyelocele. Birth Defects Res. A Clin. Mol. Teratol. 2011, 91:39-43.
42. van der Put N.M., et al. Folate, homocysteine and neural tube defects: an overview. Exp. Biol. Med. (Maywood) 2001, 226:243-270.
43. van Leeuwen F., et al. Dot1p modulates silencing in yeast by methylation of the nucleosome core. Cell 2002, 109:745-756.
44. Vogel T., et al. AF9/MILT3 interferes with TBR1 expression through epigenetic modification of histone H3K79 during development of the cerebral cortex. Int. J. Dev. Neurosci. 2010, 28:668.
45. Wang C.M., et al. Identification of histone methylation multiplicities patterns in the brain of senescence-accelerated prone mouse 8. Biogerontology 2010, 11:87-102.
46. Wang L., et al. Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am. J. Clin. Nutr. 2010, 91:1359-1367.
47. Wiedemann S.M., et al. Identification and characterization of two novel primate-specific histone H3 variants, H3.X and H3.Y. J. Cell Biol. 2010, 190:777-791.
48. Yang L., et al. Molecular cloning of ESET, a novel histone H3-specific methyltransferase that interacts with ERG transcription factor. Oncogene 2002, 21:148-152.
49. Zhang H.Y., et al. Neural tube defects and disturbed maternal folate- and homocysteine-mediated one-carbon metabolism. Exp. Neurol. 2008, 212:515-521.
50. Zhou V.W., et al. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 2011, 12:7-18.